Casdin Partners Master Fund, L's Net Worth
Casdin Partners Master Fund, L's net worth is estimated to be at least $125,863,322.37 as of 11/08/2024. CoreStreet's estimation of Casdin Partners Master Fund, L's net worth is based on their sale of stock and current holding of stock.
Casdin Partners Master Fund, L is Director at Standard BioTools Inc.. They have executed at least 27 trades of stock as per SEC Form 4 filings. Their most recent trade was for 150,000 units of LAB stock on 08/26/2024. Their biggest sale was on 07/01/2022 when they sold 3,235,548 units of MaxCyte Inc stock for $13,912,856.40. They typically trade 4 times per year.
Total value of insider buys:
- $107,425,382.07
Total value of insider sells:
- $18,437,940.30
Most recent insider trade:
- Aug. 26, 2024
Casdin Partners Master Fund, L's Insider Trading History
| Standard BioTools Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 26, 2024 | Director | 150,000 | $2.15 | Buy | $322,500.00 |
Aug. 23, 2024 | Director | 292,100 | $2.13 | Buy | $622,173.00 |
Aug. 21, 2024 | Director | 500,000 | $1.90 | Buy | $950,000.00 |
Aug. 19, 2024 | Director | 250,000 | $1.85 | Buy | $462,500.00 |
Aug. 14, 2024 | Director | 1,200,000 | $1.59 | Buy | $1,908,000.00 |
Aug. 12, 2024 | Director | 500,000 | $1.64 | Buy | $820,000.00 |
Aug. 9, 2024 | Director | 525,408 | $1.61 | Buy | $845,906.88 |
Aug. 7, 2024 | Director | 500,000 | $1.57 | Buy | $785,000.00 |
Aug. 5, 2024 | Director | 200,000 | $1.58 | Buy | $316,000.00 |
May 22, 2024 | Director | 150,000 | $2.58 | Buy | $387,000.00 |
May 20, 2024 | Director | 100,000 | $2.58 | Buy | $258,000.00 |
May 17, 2024 | Director | 352,072 | $2.56 | Buy | $901,304.32 |
May 15, 2024 | Director | 500,000 | $2.57 | Buy | $1,285,000.00 |
March 4, 2024 | Director | 250,000 | $2.57 | Buy | $642,500.00 |
| BioLife Solutions Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 19, 2023 | Major Shareholder | 927,165 | $11.19 | Buy | $10,374,976.35 |
Aug. 9, 2023 | Major Shareholder | 58,465 | $13.20 | Buy | $771,738.00 |
May 22, 2023 | Major Shareholder | 24,973 | $21.86 | Buy | $545,909.78 |
May 18, 2023 | Major Shareholder | 30,000 | $21.76 | Buy | $652,800.00 |
May 16, 2023 | Major Shareholder | 15,000 | $20.19 | Buy | $302,850.00 |
Nov. 24, 2020 | Major Shareholder | 1,600,000 | $22.50 | Buy | $36,000,000.00 |
July 1, 2020 | Major Shareholder | 685,000 | $14.50 | Buy | $9,932,500.00 |
May 22, 2020 | Major Shareholder | 476,191 | $16.14 | Buy | $7,685,722.74 |
May 14, 2020 | Major Shareholder | 1,904,762 | $10.50 | Buy | $20,000,001.00 |
Nov. 19, 2019 | Major Shareholder | 20,000 | $15.15 | Buy | $303,000.00 |
| MaxCyte Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 3, 2022 | Major Shareholder | 735,786 | $6.15 | Sell | $4,525,083.90 |
July 1, 2022 | Major Shareholder | 3,235,548 | $4.30 | Sell | $13,912,856.40 |
| Decibel Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 17, 2021 | Major Shareholder | 575,000 | $18.00 | Buy | $10,350,000.00 |